Search clinical trials for: GSK2018682
Total 3 results
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompleted
Sponsors and Collaborators
- Harvard-NIOSH Education and Research Center (ERC)
- Miami Cardiac and Vascular Institute
- Metabolic Research Unit
- Magdalena Salcedo
- Zhejiang Rehabilitation Center
- MMJ Labs LLC
- Kansas City Bioanalytical Laboratories
- Tweddle Child and Family Health Service
- Tianjin Chasesun Pharmaceutical Co., LTD
- See You At The Summit
- Unitat d'Hemostasia i Trombosi. Hospital de la Santa Creu i Sant Pau
- Canadian Cystic Fibrosis Foundation
- KAI Pharmaceuticals
- Sociedad Española de Cirugía Torácica
- Medical Information Technology (MedIT), RWTH Aachen University
- CrashCourse AB
- Colegio Oficial de Enfermeras y Enfermeros de Barcelona
- Athersys, Inc
- M.p. van den Berg, MD, PhD, professor in Cardiology
- Dr. Melody Smith, MD, MS
- View Full List
Medical Conditions
- Stage II Ovary Cancer
- Peripheral Primitive Neuroectodermal Tumor of Bone
- Malignant Tumor
- Advanced Thymic Epithelial Tumor
- Ingrown Toenail
- Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale)
- Oropharyngeal Basaloid Carcinoma
- Pesticide-Induced Parkinsonism
- Hepatitis A Virus Infection
- Skin Androgenization
- Thoraric Surgery
- Unresectable Stage III or IV Malignant Melanoma
- Combretastatin A4 Phosphate
- Anaplastic Lymphoma Kinase Gene Mutation
- Stage III Melanoma
- Discrete Choice Experiment
- Older People With Cardiovascular Disease Risk
- Peripheral Microvascular Symptoms
- Neoplasia; Intraepithelial, Cervix
- Ductal Carcinomas
- View Full List
Drug Interventions
- Paracetamol
- Botox
- 9-aminocamptothecin
- Toripalimab
- Triamcinolone
- Marijuana
- Simvastatin 10mg
- TV-46046 - 300 mg/mL (if warranted)
- Binimetinib Pill
- Ruxolitinib
- 0/0mg taken first
- LC Bead loaded with doxorubicin
- CSII,ALA,MET,RSG
- Thrombolytic Therapy
- Chloroquine (CQ) prophylaxis
- Usual care
- Cabotegravir, Rilpivirine Drug Combination
- HB0030 injection
- Group A propofol + remifentanil
- IPX203 280 mg
- View Full List
CROs by country
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Burundi
- Contract Research Organizations in Congo
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Egypt
- Contract Research Organizations in Germany
- Contract Research Organizations in Iran
- Contract Research Organizations in Latvia
- Contract Research Organizations in Malaysia
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Panama
- Contract Research Organizations in Romania
- CRO list by country